Jump to main content
Jump to site search

Issue 25, 2012
Previous Article Next Article

Catalytic metallodrugs targeting HCV IRES RNA

Author affiliations

Abstract

A catalytic metallodrug that targets stem-loop IIb of the internal ribosomal entry site (IRES) RNA of hepatitis C virus (HCV) demonstrates enzyme-like turnover with KM of 0.85 μM, kcat of 0.53 min−1, and a turnover number of 31.9 for Cu·GGHYrFK-amide (1-Cu), and yielded an antiviral activity (IC50) of 0.58 μM in an HCV cellular replicon assay.

Graphical abstract: Catalytic metallodrugs targeting HCV IRES RNA

Back to tab navigation

Supplementary files

Publication details

The article was received on 25 Nov 2011, accepted on 12 Jan 2012 and first published on 16 Jan 2012


Article type: Communication
DOI: 10.1039/C2CC17377H
Citation: Chem. Commun., 2012,48, 3118-3120
  •   Request permissions

    Catalytic metallodrugs targeting HCV IRES RNA

    S. Bradford and J. A. Cowan, Chem. Commun., 2012, 48, 3118
    DOI: 10.1039/C2CC17377H

Search articles by author

Spotlight

Advertisements